Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Farudodstat in Alopecia Areata (FAST-AA)
NCT05865041Phase 2Recruiting
- Sponsor
- ASLAN Pharmaceuticals
- Start
- Apr 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of farudodstat in alopecia areata, sponsored by ASLAN Pharmaceuticals. Started Apr 2023; status: recruiting.
02
Drugs
farudodstat
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05865041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05865041.